Show simple item record

Case report: Serotoninergic and cholinergic syndromes induced by self-medication

dc.contributor.authorOrozco-Solano, Sofía
dc.contributor.authorSilva-Castro, Martha Milena
dc.contributor.authorMachuca González, Manuel
dc.date.accessioned2024-01-18T09:43:56Z
dc.date.available2024-01-18T09:43:56Z
dc.date.issued2023-02-16
dc.identifier.citationOrozco-Solano S, Silva-Castro MM, Machuca M. Case report: Serotoninergic and cholinergic syndromes induced by self-medication. Front Pharmacol. 2023 Feb 16;14:1080249. doi: 10.3389/fphar.2023.1080249. PMID: 36874029; PMCID: PMC9978782.es
dc.identifier.issn1663-9812
dc.identifier.urihttps://hdl.handle.net/20.500.12412/4941
dc.description.abstractSelf-medication is a part of the self-care practices carried out by the elderly in their environment. The aim of this case report is to show how the self-medication of fluoxetine and dimenhydrinate in an older adult can induce serotoninergic and cholinergic syndromes, showing symptoms such as nausea, tachycardia, tremor, loss of appetite, memory loss, decreased vision, falls, and increased urination. An older adult who has been diagnosed with arterial hypertension, dyslipidemia, diabetes mellitus, and a recent diagnosis of essential thrombosis is the subject of this case report. After the analysis of the case, cessation of fluoxetine was recommended to avoid withdrawal symptoms, therefore decreasing the need for dimenhydrinate and the medicines used for dyspepsia. After the recommendation, the patient showed an improvement in the symptoms. Finally, the comprehensive evaluation process of the medication in the Medicines Optimization Unit achieved the detection of the problem and improved the patient’s health condition.es
dc.language.isoenges
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleCase report: Serotoninergic and cholinergic syndromes induced by self-medicationes
dc.typearticlees
dc.identifier.doi10.3389/fphar.2023.1080249
dc.issue.number14es
dc.journal.titleFrontiers in Pharmacologyes
dc.page.initial1es
dc.page.final5es
dc.rights.accessRightsopenAccesses
dc.subject.keywordAdverse drug reactiones
dc.subject.keywordCholinergic Syndromees
dc.subject.keywordPharmaceutical Carees
dc.subject.keywordComprehensive Medication Managementes
dc.subject.keywordCase reportes
dc.subject.keywordSerotonergic syndromees
dc.volume.numberFeb 16es


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional